Food supplements in France: what the DGCCRF checks

Selling food supplements in France: declaration before sale, authorised ingredients, labelling, health claims, medicinal claims and DGCCRF penalties.

What does the DGCCRF check on food supplements?

When the DGCCRF inspects a food supplement sold in France, it checks four things: that the product was declared before it was first placed on the French market, that each ingredient is authorised and used within its conditions of use, that the label carries the mandatory statements, and that every health claim, on the pack, the website or social media, is authorised. Claims that a supplement prevents, treats or cures a disease are prohibited, and can lead to the product being treated as an unauthorised medicine.

Updated: November 2026. Key provisions: Decree No. 2006-352 of 20 March 2006 on food supplements; Regulations (EC) No 1924/2006, (EU) No 432/2012, (EU) No 1169/2011 and (EU) 2015/2283; Articles L. 121-4, L. 132-2, L. 441-1 and L. 454-1 of the French Consumer Code; Articles L. 5111-1 and L. 5421-2 of the French Public Health Code.

Food supplements are foods, but they sit at the junction of several sets of rules: EU food law, a national decree and ministerial orders, the Consumer Code and the Public Health Code. Declarations are filed with the Ministry of Agriculture. Labelling, claims and commercial practices are checked by the DGCCRF (the French authority for competition, consumer affairs and fraud control) and its local offices, the DDPP (departmental directorates for the protection of populations). This article is written for foreign brands, importers and online sellers whose supplements are sold to consumers in France. If you have received a request for documents or a notice, a lawyer for DGCCRF and DDPP inspections can assess your exposure before you answer.

Would you like to discuss your situation? Book a consultation:

CLICK HERE TO BOOK YOUR ONLINE CONSULTATION

What counts as a food supplement

A food supplement is a food intended to supplement the normal diet, which is a concentrated source of nutrients or other substances with a nutritional or physiological effect, sold in dose form: capsules, tablets, pills, sachets of powder, ampoules, dropper bottles and similar forms taken in small measured quantities (Article 2 of Decree No. 2006-352). The decree does not apply to medicines as defined by the French Public Health Code (Article 1).

Products defined as food supplements may only be sold under the name "complément alimentaire" (Article 9).

Declaring a supplement before it is sold

The standard declaration

The person responsible for first placing a food supplement on the French market must inform the minister responsible for agriculture, sending a model of the label (Article 15 of the decree). Since 5 February 2023, the decree designates the minister responsible for agriculture as the recipient of declarations, which are filed in practice through that ministry's online declaration service. The composition shown on the label must meet the safety conditions of the decree. A declaration is a notification, not an authorisation: the product's compliance can be checked at any time.

Ingredients lawfully sold in another EU or EEA country

If the product contains a substance, plant or plant preparation that is not on the French lists, but is lawfully manufactured or marketed in another EU member state or EEA country, the importer or manufacturer established in the EU or EEA must file a specific declaration. It must identify the declarant, include a model of the label, prove the lawful marketing elsewhere and provide the data available to assess the ingredient (Article 16). The minister has two months from the complete file to respond, and silence amounts to authorisation. A refusal must be reasoned, either by the lack of proof of lawful marketing or by scientific evidence of a health risk, and the declarant is invited to comment.

New ingredients and higher nutrient levels

Any person can ask for an ingredient to be added to the French lists. The application goes to the Ministry of Agriculture, which sends the complete file to ANSES (the French agency for food, environmental and occupational health and safety) for an opinion within four months (Article 17). The same procedure applies to requests to change the maximum amounts of vitamins and minerals (Article 18).

Distributors and online resellers

It is prohibited to import for release onto the EU market, hold for sale, sell or distribute food supplements that do not comply with the decree (Article 20). A distributor that does not file the declaration itself is therefore still exposed if it sells a product that was never declared. Under EU law, food business operators must also ensure that the foods under their control meet the requirements of food law (Article 17(1) of Regulation (EC) No 178/2002).

Procedure When it applies What is filed Outcome
Declaration (Article 15 of Decree No. 2006-352) All ingredients already on the French lists, within their conditions of use Declaration to the minister responsible for agriculture with a model of the label Notification; compliance can be checked at any time
Mutual recognition (Article 16) Substance, plant or preparation not on the French lists, but lawfully made or sold in another EU or EEA country Identification, label, proof of lawful marketing, assessment data Reply within two months of the complete file; silence means authorisation; reasoned refusal
Addition to the lists (Article 17) Request to add or amend a substance or plant in the ministerial orders Application with the file needed for assessment ANSES opinion within four months of the complete file, then decision of the minister
Nutrient levels (Article 18) Change to the maximum amounts of vitamins and minerals Same procedure as Article 17 Same as Article 17
Novel food (Regulation (EU) 2015/2283) Food not used to a significant degree in the EU before 15 May 1997 EU authorisation and inclusion in the Union list No sale before inclusion; conditions of use and labelling of the list apply

Authorised ingredients

Only the following can be used to make food supplements: nutrients and other substances with a nutritional or physiological purpose, plants and plant preparations, each within the conditions set by the decree, other ingredients whose use in food is traditional or authorised under the novel food rules, and authorised additives, flavourings and processing aids (Article 4).

  • Vitamins and minerals can only be used under a ministerial order setting the list of authorised forms, their purity criteria and maximum amounts (Article 5).
  • Other substances are allowed if authorised under EU rules on specific food categories, or by a ministerial order after an ANSES opinion, within their conditions of use (Article 6). Substances with exclusively pharmacological properties are excluded by definition (Article 2).
  • Plants and plant preparations are allowed if traditionally considered as food, or if authorised by a ministerial order after an ANSES opinion, within their conditions of use (Article 7). Plants with pharmacological properties intended for exclusively therapeutic use are excluded (Article 2).

The EU novel food rules apply on top. A novel food is a food that was not used for human consumption to a significant degree in the EU before 15 May 1997 and falls into one of the listed categories (Article 3 of Regulation (EU) 2015/2283). Only novel foods authorised and included in the Union list may be placed on the market, and only within the conditions of use and labelling set by that list (Article 6). An ingredient sold without restriction outside Europe may therefore be prohibited in the EU, whatever the label says.

Labelling rules specific to supplements

Regulation (EU) No 1169/2011 on food information applies to supplements as to any prepacked food. The decree adds the following (Articles 10 to 12):

  • the names of the categories of nutrients or substances that characterise the product;
  • the recommended daily portion;
  • a warning not to exceed the stated daily dose;
  • a statement that supplements should not be used as a substitute for a varied diet;
  • a warning to keep the product out of the reach of young children;
  • the amounts of nutrients and substances in figures, per recommended daily portion, and for vitamins and minerals also as a percentage of the reference values.

The labelling, presentation and advertising of supplements must not state or suggest that a balanced and varied diet cannot provide sufficient nutrients in general (Article 11). This applies to websites and social media content, not only to the pack.

For online sales, mandatory food information, except the date of minimum durability or "use by" date, must be available before the purchase is concluded, and all mandatory particulars must be available at delivery (Article 14 of Regulation (EU) No 1169/2011). A product page that shows claims missing from the actual label, or a photo of an outdated label, can create problems of its own.

Health claims under Regulation (EC) No 1924/2006

Prohibited unless authorised

Health claims are prohibited unless they comply with the general requirements of Regulation (EC) No 1924/2006, are authorised, and are included in the lists of authorised claims (Article 10(1)). The list of permitted general function claims is set out in Regulation (EU) No 432/2012, and each claim may only be used in compliance with the conditions stated there, such as a minimum amount of the nutrient (Article 1 of that regulation). Wording that departs from the authorised claim, or a product that does not meet the conditions of use, may not be covered by the authorisation.

Mandatory accompanying statements

A health claim is only permitted if the labelling, or failing that the presentation and advertising, also includes a statement on the importance of a varied and balanced diet and a healthy lifestyle, the quantity and pattern of consumption needed for the claimed effect, where appropriate a statement for people who should avoid the product, and a warning where excess consumption is a risk (Article 10(2)).

General wellbeing claims

References to general, non-specific benefits for overall good health or health-related wellbeing, such as "vitality" or "balance", may only be made if accompanied by a specific authorised health claim (Article 10(3)).

Claims that are never allowed

Claims suggesting that health could be affected by not consuming the food, claims referring to the rate or amount of weight loss, and claims referring to recommendations of individual doctors or health professionals are not allowed (Article 12). Claims on plants call for particular care: many are still awaiting assessment at EU level, and their status should be checked case by case before use.

Medicinal claims and the risk of being treated as a medicine

Disease claims are prohibited

The labelling, presentation and advertising of food supplements must not attribute to them, or refer to, properties of preventing, treating or curing a human disease (Article 8 of the decree). EU law sets the same rule for all foods, including advertising and presentation (Article 7(3) and (4) of Regulation (EU) No 1169/2011). Under the Consumer Code, falsely claiming that a product can cure diseases, dysfunctions or malformations is a commercial practice deemed misleading in all circumstances (Article L. 121-4, 16°).

Medicine by presentation

A medicine includes any substance or composition presented as having curative or preventive properties with regard to human diseases, and any substance that can restore, correct or modify physiological functions through a pharmacological, immunological or metabolic action (Article L. 5111-1 of the French Public Health Code). In case of doubt, a product that may fall within both the definition of a medicine and another category is considered a medicine. Presentation is assessed as a whole: name, visuals, dosage instructions, testimonials, references to diseases, and what the brand and its partners say online.

Consequences

Selling or distributing an industrially manufactured medicine without a marketing authorisation, or advertising it, is punishable by five years' imprisonment and a €375,000 fine. The penalties rise to seven years and €750,000 when the offence may cause a serious risk to human health, or is committed through a telecommunications network to an unspecified public, which covers online sales (Article L. 5421-2 of the Public Health Code).

Influencers promoting supplements

The rules on online advertising, including Regulation (EC) No 1924/2006, apply to commercial influencer activity (Article 3 of Law No. 2023-451 of 9 June 2023). Influencers may not promote non-therapeutic products presented as comparable, preferable or substitutable to therapeutic treatments, under the penalties of Article L. 132-2 of the Consumer Code (Article 4, II and IX). For contracts, disclosure and the brand's own exposure, see our article on influencer marketing rules in France.

The inspection and its outcomes

What inspectors may look at

An inspection may start with a visit or online: the brand's website, marketplace listings and social media accounts, followed by test purchases and laboratory analyses of the actual content. Inspectors then compare the declaration, the label, the product page and the promotional content, and ask for documents: the declaration file, technical data and certificates for raw materials, plant extract specifications, manufacturing contracts, the basis for each claim and influencer contracts. The person responsible for first placing the product on the market must, on request, disclose the nature and results of the checks made to ensure that the ingredients are safe (Article 3 of the decree).

Foreign sellers

The offence of misleading commercial practice is committed as soon as the practice is carried out, or produces its effects, in France (Article L. 132-1 of the Consumer Code). A brand established abroad that sells to French consumers through its own website or a marketplace is therefore within reach of French rules.

Possible outcomes

Depending on the seriousness of the breach and the health risk, the outcome can range from a warning to an injunction to comply within a set time limit, issued after an adversarial procedure and possibly with a daily penalty (Article L. 521-1), and to a report sent to the public prosecutor. Before prosecution starts, the authority can propose a criminal transaction, with the prosecutor's agreement, for petty offences and for offences under the Consumer Code punishable by up to three years' imprisonment, including misleading practices; the amount must be lower than the maximum fine (Article L. 523-1).

Breach Legal basis Maximum penalty (individual) Company
Breach of the labelling and composition rules of the decree Consumer Code, R. 451-1; Criminal Code, 131-13 Fifth-class petty offence: €1,500 (€3,000 for a repeat offence where the regulation so provides) Five times the fine (Criminal Code, 131-41)
Misleading commercial practice, including false claims to cure diseases Consumer Code, L. 121-2 to L. 121-4, L. 132-2 and L. 132-2-1 2 years and €300,000, up to 10% of average annual turnover or 50% of the advertising costs; 5 years and €750,000 online; 3 years if contracts followed Five times the fine (Criminal Code, 131-38)
Deception on composition or substantial qualities, such as the actual content Consumer Code, L. 441-1, L. 454-1 and L. 454-4 3 years and €300,000, up to 10% of average annual turnover Five times the fine (Criminal Code, 131-38)
Influencer promoting a product as a substitute for treatment Law No. 2023-451, Article 4, II and IX Penalties of L. 132-2 of the Consumer Code; ban on the activity Five times the fine (Criminal Code, 131-38)
Product treated as a medicine sold or advertised without authorisation Public Health Code, L. 5111-1 and L. 5421-2 5 years and €375,000; 7 years and €750,000 if serious health risk or sold online to the public Five times the fine (Criminal Code, 131-38)
Criminal transaction Consumer Code, L. 523-1 Amount lower than the maximum fine; prosecutor's agreement Same rule

Responding to an inspection

Removing one sentence from a website is rarely enough. The first task is to rebuild the file: the products concerned, their declarations, successive versions of labels and product pages, influencer content and supply contracts. The next is to check whether the issue is isolated or affects other products, and to distinguish a labelling defect from a claim that could be read as medicinal. Written answers to the authority commit the company, and corrections must be consistent across all channels, including partners. For the general framework, see our guide to misleading commercial practices in France.

Frequently asked questions

Do I need to register a food supplement before selling it in France?

Yes. The person responsible for first placing it on the French market must declare it to the Ministry of Agriculture with a model of the label (Article 15 of Decree No. 2006-352). Products with ingredients not on the French lists follow the procedures of Articles 16 and 17.

Who files the declaration: the brand, the importer or the retailer?

The person responsible for first placing the product on the French market, usually the manufacturer, the brand or the importer. A retailer does not file it again, but selling a supplement that does not comply with the decree is prohibited (Article 20), so it should check that the product was declared.

Can I sell in France a supplement that is legal in another EU country?

Often, through the mutual recognition declaration of Article 16. The minister has two months from the complete file to respond, and silence amounts to authorisation. A refusal must be based on missing proof of lawful marketing or on scientific evidence of a health risk.

Which health claims can I use on a food supplement in France?

Only claims authorised and included in the EU lists, such as the list in Regulation (EU) No 432/2012, used under their conditions of use and with the mandatory accompanying statements (Article 10 of Regulation (EC) No 1924/2006).

What is the difference between a health claim and a medicinal claim?

A health claim links a food to health, for example a nutrient's contribution to a normal body function, and is allowed if authorised. A medicinal claim says that the product prevents, treats or cures a disease: it is prohibited for supplements (Article 8 of the decree) and can make the product a medicine by presentation.

Can a food supplement be treated as a medicine in France?

Yes, by its presentation, if it is presented as curing or preventing diseases, or by its function, if it acts pharmacologically. In case of doubt, the medicine qualification prevails (Article L. 5111-1 of the Public Health Code). Selling an unauthorised medicine carries up to five years' imprisonment and €375,000, or seven years and €750,000 online (Article L. 5421-2).

Is the brand liable for what influencers say about its supplements?

The influencer has its own obligations under Law No. 2023-451. Sponsored content is also part of the brand's commercial communication, and a brand that ordered, approved or shared the content may see its own liability examined. The contract and the record of approvals then matter.

What are the penalties for an unauthorised health claim?

Outcomes range from an injunction to a criminal report. A misleading claim can be a misleading commercial practice: two years' imprisonment and €300,000 for individuals, which can be raised to 10% of average annual turnover, with five years and €750,000 when committed online (Article L. 132-2), and five times the fine for companies (Article 131-38 of the French Criminal Code).

Key actions

  • Before launch: check each ingredient against the French lists and the EU novel food list, then file the declaration with the Ministry of Agriculture.
  • Labels and pages: check the mandatory statements of the decree and align the product page, the label and the declared formula.
  • Claims: keep a register of each claim used, its authorised wording and its conditions of use, and share it with influencers.
  • Request for documents or notice received: rebuild the file and have the answer reviewed before sending it.

Article written by Guillaume Leclerc, lawyer at the Paris Bar, 34 avenue des Champs-Élysées, Paris. Working languages: French and English.